Literature DB >> 23362108

Epigenetic regulation of the X-linked tumour suppressors BEX1 and LDOC1 in oral squamous cell carcinoma.

Chia-Huei Lee1, Thian-Sze Wong, Jimmy Yu-Wai Chan, Shao-Chun Lu, Pinpin Lin, Ann-Joy Cheng, Yin-Ju Chen, Jeffrey Shu-Ming Chang, Shu-Huei Hsiao, Yu-Wei Leu, Chuan-I Li, Jenn-Ren Hsiao, Jang-Yang Chang.   

Abstract

The strong associations between oral squamous cell carcinoma (OSCC) and dietary habits such as alcohol consumption (A), betel quid chewing (B) and cigarette smoking (C) and its predominance in men have been well documented; however, systemic analysis of OSCC is limited. Our study applied high-throughput screening methods to identify causative epigenetic targets in a cohort of men with ABC-associated OSCC. We identified BEX1 and LDOC1 as two epigenetically silenced X-linked tumour suppressors and demonstrated a functional link between the transcription of BEX1 and LDOC1 and promoter hypermethylation. Methylation of the BEX1 and LDOC1 promoters was associated significantly (p < 0.0001) with OSCC and were detected in 75% (42/56) and 89% (50/56) of the samples, respectively. We observed concordant increases in the methylation of both genes in 71% (40/56) of the tumours, and potent in vitro and in vivo growth inhibitory effects in OSCC cells ectopically expressing BEX1 and/or LDOC1. Restored expression of BEX1 and LDOC1 suppressed the nuclear factor-κB (NF-κB) signalling pathway, which is the most frequently hyperactivated signalling pathway in OSCC. This suppression might result from decreased p50 and p65 expression. These findings suggest that silencing of BEX1 and LDOC1 by promoter hypermethylation might represent a critical event in the molecular pathogenesis of OSCC and account for the oncogenic effects of ABC exposure and the male predominance of OSCC occurrence. Microarray data are available in the Gene Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/)
Copyright © 2013 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23362108     DOI: 10.1002/path.4173

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  36 in total

1.  A pilot study evaluating genetic alterations that drive tobacco- and betel quid-associated oral cancer in Northeast India.

Authors:  Dhirendra Singh Yadav; Indranil Chattopadhyay; Anand Verma; Thoudam Regina Devi; L C Singh; Jagannath Dev Sharma; Amal Ch Kataki; Sunita Saxena; Sujala Kapur
Journal:  Tumour Biol       Date:  2014-06-19

2.  Tumour cell-derived WNT5B modulates in vitro lymphangiogenesis via induction of partial endothelial-mesenchymal transition of lymphatic endothelial cells.

Authors:  S-H Wang; J S Chang; J-R Hsiao; Y-C Yen; S S Jiang; S-H Liu; Y-L Chen; Y-Y Shen; J-Y Chang; Y-W Chen
Journal:  Oncogene       Date:  2016-09-05       Impact factor: 9.867

3.  Domesticated transposable element gene products in human cancer.

Authors:  Jesse D Riordan; Adam J Dupuy
Journal:  Mob Genet Elements       Date:  2013-10-14

4.  Leucine Zipper Down-regulated in Cancer-1 (LDOC1) interacts with Guanine nucleotide binding protein-like 3-like (GNL3L) to modulate Nuclear Factor-kappa B (NF-κB) signaling during cell proliferation.

Authors:  Indu Jose Thoompumkal; Krishnan Rehna; Kumaraswamy Anbarasu; Sundarasamy Mahalingam
Journal:  Cell Cycle       Date:  2016-10-20       Impact factor: 4.534

Review 5.  Deciphering the Role of the Barr Body in Malignancy: An insight into head and neck cancer.

Authors:  Deepti Sharma; George Koshy; Shruti Gupta; Bhushan Sharma; Sonal Grover
Journal:  Sultan Qaboos Univ Med J       Date:  2018-01-10

6.  Altered histone mark deposition and DNA methylation at homeobox genes in human oral squamous cell carcinoma.

Authors:  Katarzyna M Marcinkiewicz; Lorraine J Gudas
Journal:  J Cell Physiol       Date:  2014-10       Impact factor: 6.384

7.  Combination of Imatinib Mesylate and AKT Inhibitor Provides Synergistic Effects in Preclinical Study of Gastrointestinal Stromal Tumor.

Authors:  Phillip Zook; Harsh B Pathak; Martin G Belinsky; Lawrence Gersz; Karthik Devarajan; Yan Zhou; Andrew K Godwin; Margaret von Mehren; Lori Rink
Journal:  Clin Cancer Res       Date:  2016-07-01       Impact factor: 12.531

8.  The brain expressed x-linked gene 1 (Bex1) regulates myoblast fusion.

Authors:  Chunhui Jiang; Jing-Hua Wang; Feng Yue; Shihuan Kuang
Journal:  Dev Biol       Date:  2015-11-14       Impact factor: 3.582

9.  Portrait of DNA methylated genes predictive of poor prognosis in head and neck cancer and the implication for targeted therapy.

Authors:  Jessica Hier; Olivia Vachon; Allison Bernstein; Iman Ibrahim; Alex Mlynarek; Michael Hier; Moulay A Alaoui-Jamali; Mariana Maschietto; Sabrina Daniela da Silva
Journal:  Sci Rep       Date:  2021-05-11       Impact factor: 4.379

10.  NF-κB upregulation through epigenetic silencing of LDOC1 drives tumor biology and specific immunophenotype in Group A ependymoma.

Authors:  Andrea M Griesinger; Davis A Witt; Sydney T Grob; Sabrina R Georgio Westover; Andrew M Donson; Bridget Sanford; Jean M Mulcahy Levy; Randall Wong; Daniel C Moreira; John A DeSisto; Ilango Balakrishnan; Lindsey M Hoffman; Michael H Handler; Kenneth L Jones; Rajeev Vibhakar; Sujatha Venkataraman; Nicholas K Foreman
Journal:  Neuro Oncol       Date:  2017-10-01       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.